Targeted therapy of lung cancer. Edited: Saljia R.

Translation of the English -language publication of the book “Targeted Light cancer”, which is included in the series “Modern Tumor Research”, contains the latest achievements in this area, including studies of EGFR, Alk, Ros, Brab, Ret, Met, Her, NTRK, KRAS inhibitors. , Pdl, ctla,

vegf, as well as epigenetic modulators DNMT and HDAC.

The book consists of 11 chapters. Each of them is written by a leading medical oncologist specializing in thoracic oncology, and is dedicated to a certain target. The material is well structured, covers the mechanisms that underlie signal transmission, potential interactions between the target and the descending signaling way, as well as the mechanisms of resistance. The current problems of using various biomarkers are affected to assess the prognosis and course of the disease, as well as a response to the treatment. Particular attention is paid to the latest data from clinical studies and other works of major oncological centers.

This manual is intended for oncologists of all specialties, specialists in the field of experimental and clinical chemotherapy and molecular diagnostics, orders, students, graduate students of medical universities, scientists, scientists, scientists studying the applied and academic aspects of lung cancer.